SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-036485
Filing Date
2023-08-01
Accepted
2023-08-01 16:16:04
Documents
12
Period of Report
2023-08-01
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K itrm-20230801.htm   iXBRL 8-K 63756
  Complete submission text file 0000950170-23-036485.txt   189205

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT itrm-20230801.xsd EX-101.SCH 2469
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT itrm-20230801_lab.xml EX-101.LAB 14980
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT itrm-20230801_pre.xml EX-101.PRE 10995
6 EXTRACTED XBRL INSTANCE DOCUMENT itrm-20230801_htm.xml XML 5068
Mailing Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24
Business Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38503 | Film No.: 231131915
SIC: 2834 Pharmaceutical Preparations